Bristol hires ImClone manufacturing exec
Executive Summary
ImClone Senior VP-Manufacturing Operations & Product Development Joseph Tarnowski will join Bristol-Myers Squibb as senior VP-biologics, manufacturing and process development. ImClone VP-Manufacturing Richard Crowley will take over for Tarnowski as senior VP- biopharmaceutical operations, overseeing the company's biologics manufacturing operations. Crowley joined ImClone in 2000 as assistant VP-manufacturing and was promoted to VP-manufacturing in 2002. Prior to joining ImClone, Crowley held positions at BASF, Genencor International, Eastman Kodak and Monsanto...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.